
Zentek Ltd. — Investor Relations & Filings
Zentek Ltd. is an intellectual property (IP) development and commercialization company specializing in nanotechnology. It leverages expertise in nanomaterials, particularly graphene, to research, develop, and patent advanced solutions for the healthcare, safety, and environmental sectors. The company's primary focus is on creating technologies for prevention, detection, and treatment. Its flagship commercial product is ZenGUARD™, a proprietary graphene-based antimicrobial coating that enhances the pathogen-filtering efficacy of personal protective equipment like surgical masks. Zentek's development pipeline also includes other advanced materials, such as graphite-based fire-retardant products, which it advances toward commercialization through strategic partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-13 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-06 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-28 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-22 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-16 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-15 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 45626550 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-13 | English | ||
| 41929009 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-06 | English | ||
| 38023632 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-28 | English | ||
| 35277900 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-22 | English | ||
| 34650021 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-16 | English | ||
| 34596920 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-15 | English | ||
| 34417504 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-13 | English | ||
| 33135818 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-01 | English | ||
| 33040816 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-03-25 | English | ||
| 32199603 | 6-K Filing | 2026-01-29 | English | ||
|
2025
5 filings
| |||||
| 13569824 | FORM 6-K | 2025-12-17 | English | ||
| 13569823 | FORM 6-K | 2025-11-25 | English | ||
| 13569826 | FORM 6-K | 2025-11-21 | English | ||
| 13569829 | FORM 6-K | 2025-11-14 | English | ||
| 13569827 | FORM 6-K | 2025-11-05 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
Zentek Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34277/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34277 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34277 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34277 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34277}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zentek Ltd. (id: 34277)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.